Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Changes in the level of certain hemostatic factors during treatment with lovastatin in patients with primary hyperlipoproteinemia and phenotype IIa and IIb].

Przeglad lekarski - 1 Jan 1992

Idzior-Waluś B

Abstract excerpt

12 weeks of hypolipidemic therapy with lovastatin in patients with primary hyperlipoproteinemia phenotype IIa (20 persons) and IIb (10 persons), apart from decrease of serum total cholesterol, LDL-cholesterol and apolipoprotein B concentration caused significant decrease of antithrombin III, plasminogen and Factor VII activity. The mean decrease in antithrombin III activity (from 103.5 to 91.7% in HLP IIa and...

Topics

Antithrombin III
Factor VII
Humans
Hyperlipoproteinemia Type II
Lovastatin
Phenotype
Plasminogen

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 1308287

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-1308287-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Changes in the level of certain hemostatic factors during treatment with lovastatin in patients with primary hyperlipoproteinemia and phenotype IIa and IIb].PMID 1308287Read ↗

[Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration].Semantic proximity Read ↗

[Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia].Semantic proximity Read ↗

[LDL apheresis in the treatment of hyperlipoproteinemia].Semantic proximity Read ↗

[Phenotyping of hyperlipoproteinemias in atherosclerosis patients treated at Kislovodsk].Semantic proximity Read ↗

[LDL phenotype A and B in ischemic stroke].Semantic proximity Read ↗

[The effect of hypolipemic treatment on the pharmacokinetics of propranolol].Semantic proximity Read ↗

[Beta2-glycoprotein I polymorphism].Semantic proximity Read ↗

[Comparative study of peripheral circulation, lipid metabolism and hemocoagulation in families with atherosclerosis and diabetes mellitus].Semantic proximity Read ↗

[Distributions of polymorphisms of genes of some components of hemostasis in patients with ischemic heart disease].Semantic proximity Read ↗

[Polymorphism of GPIIIA platelet glycoprotein gene PIA1/A2 compared to plasma hemostasis in myocardial infarction patients].Semantic proximity Read ↗

[The effect of hemosorption on the lipid and lipoprotein composition of the blood plasma].Semantic proximity Read ↗

[Role of genetic polymorphisms of the hemostatic system in the development of multiple organ dysfunctions in acute disseminated intravascular coagulation].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.